glp-1 and cancer treatment Glucagon-like peptide-1 receptor agonists risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials GLP-1 Medications and Cancer Survivorship:

Neuropsychopharmacology 42 , 14711479 (2017)

Though GLP-1s existed in the diabetes market as early as 2010, it was the weight loss efficacy and widespread adoption of Ozempic that thrust the drug class into the spotlight

Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimers disease

o thi c t: Khng ch l thnh phn chng oxy ha, Glutathione cn tham gia vo h thng gii c t nhin, gip loi b kim loi nng v cc cht c tch t gy hi cho da v sc khe tng th

PMID: 35444236 Cell Death Dis Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase

that's guesswork with needles